Clinical trial
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Clinical Study to Evaluate the Efficacy and Safety of Clascoterone Cream 1% in Treatment of Subjects With Facial Acne Vulgaris
NCT06403501 is registered in ClinicalTrials.gov with Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Clinical Study to Evaluate the Efficacy and Safety of Clascoterone Cream 1% in Treatment of Subjects With Facial Acne Vulgaris
- Lead sponsor
- Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- May 20, 2024
- Completion date
- October 31, 2026
- Enrollment
- 692 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.